Stock Analysis on Net
Stock Analysis on Net

Marathon Oil Corp. (NYSE:MRO)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 4, 2022.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Marathon Oil Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Marathon Oil Corp., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Accounts payable
Payroll and benefits payable
Accrued taxes
Other current liabilities
Long-term debt due within one year
Current liabilities held for sale
Current liabilities
Long-term debt, excluding due within one year
Deferred tax liabilities
Defined benefit postretirement plan obligations
Asset retirement obligations
Deferred credits and other liabilities
Noncurrent liabilities held for sale
Noncurrent liabilities
Total liabilities
Preferred stock, no par value; no shares issued or outstanding
Common stock, par value $1 per share
Common stock, held in treasury, at cost
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Accounts payable
The accounts payable balance exhibited a general increasing trend over the periods, rising from $1,081 million at the end of Q1 2017 to $1,523 million by the end of Q2 2022. Some fluctuations occurred, notably a dip in Q2 2020, likely reflecting temporarily reduced payables during that quarter.
Payroll and benefits payable
This liability showed variability with some peaks and troughs, reaching a high of $154 million in Q4 2017 before decreasing to $50 million by Q2 2022. The general pattern suggests some volatility but an overall decline in recent quarters.
Accrued taxes
Accrued taxes fluctuated significantly, peaking around $181 million in Q4 2017 and again reaching $169 million in Q1 2022. The values show cyclical tendencies but no clear sustained upward or downward trend.
Other current liabilities
The amount for other current liabilities varied substantially across the timeline, with a notable peak at $461 million in Q2 2021, followed by a decline. These variations suggest episodic changes in other short-term obligations.
Long-term debt due within one year
Data for this item are incomplete in early periods but show a downward trajectory from $600 million in Q4 2018 to $273 million by Q2 2022, indicating repayments or refinancing resulting in reduced short-term debt obligations.
Current liabilities held for sale
This category appeared sporadically with relatively low values, peaking at $103 million in Q1 2019, implying occasional disposals or reclassifications of current liabilities.
Current liabilities
Total current liabilities decreased notably from $3,099 million in Q1 2017 to $1,065 million in Q2 2020, before rebounding to $2,377 million by Q2 2022. This pattern reflects significant short-term liability reductions followed by partial recoveries.
Long-term debt, excluding due within one year
This type of liability remained relatively stable around $5,500 million through most quarters until a decline started in Q3 2019, reducing progressively to approximately $3,709 million by Q2 2022, indicating ongoing debt repayments or restructuring.
Deferred tax liabilities
Deferred tax liabilities predominantly decreased over the periods, falling from $800 million in Q1 2017 to roughly $146 million by Q2 2022, signaling changes in taxable temporary differences or tax planning strategies.
Defined benefit postretirement plan obligations
These obligations experienced a general downward trend, declining from $365 million in Q1 2017 to $124 million by Q2 2022, reflecting possible actuarial gains, benefit payments, or plan modifications.
Asset retirement obligations
This liability showed a marked decline from $1,622 million in Q1 2017 to below $300 million by Q2 2022, representing potential asset retirements completed or changes in estimates related to future retirement costs.
Deferred credits and other liabilities
Values here fluctuated moderately, often staying within a $100 million range, and showed a tendency to decline slightly over time from $221 million in Q1 2017 to $120 million by Q2 2022.
Noncurrent liabilities held for sale
This item showed intermittent occurrences, peaking sharply at $963 and $964 million in Q1 and Q2 2019, respectively, signaling significant noncurrent liabilities classified as held for sale during that period. The line appears absent afterward.
Noncurrent liabilities
The total noncurrent liabilities declined steadily from $8,854 million in Q1 2017 to $4,377 million by Q2 2022, highlighting overall debt reduction and liability management over the analyzed quarters.
Total liabilities
Total liabilities dropped consistently from $11,953 million in Q1 2017 to approximately $6,308 million by Q2 2021, followed by a slight increase up to $6,754 million in Q2 2022, reflecting a significant deleveraging trend with some recent liability growth.
Common stock and treasury stock
Common stock remained constant at $937 million throughout the periods, while common stock held in treasury grew in absolute negative value from -$3,314 million in Q1 2017 to -$6,118 million in Q2 2022, indicating ongoing share repurchases or treasury stock accumulation.
Additional paid-in capital
Additional paid-in capital stayed relatively steady around $7,000 million, with minor fluctuations but no marked trend emerging over the period.
Retained earnings
Retained earnings fluctuated, declining from $7,673 million in Q1 2017 to a low of approximately $6,466 million in Q4 2020, then recovering robustly to $9,433 million by Q2 2022, suggesting variable profitability and dividend policies over time with recent accumulation.
Accumulated other comprehensive income (loss)
This component improved from negative values in early periods to positive territory, rising from -$48 million in Q1 2017 to $94 million by Q2 2022, indicating favorable adjustments perhaps related to cumulative translation adjustments, unrealized gains, or other comprehensive income items.
Stockholders’ equity
Equity remained relatively stable, fluctuating between about $10,500 million and $12,500 million through most quarters. Though there was a dip to approximately $10,561 million in Q4 2020, equity rebounded to $11,532 million by Q2 2022, reflecting overall resilience in book value despite earnings volatility.
Total liabilities and stockholders’ equity
The aggregate of liabilities and equity decreased from $24,537 million in Q1 2017 to $18,567 million in Q2 2020, with a gradual rise to $18,286 million by Q2 2022, consistent with reduced leverage and balance sheet contraction over the analyzed timeframe.